Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 1993
Optimizing transmembrane domain helicity accelerates insulin receptor internalization and lateral mobility
E Goncalves, K Yamada, H S Thatte, et al.
European Journal of Sport Science
|
August 23, 2014
Motivation towards dual career of European student-athletes
Corrado Lupo, Flavia Guidotti, Carlos E Goncalves, et al.
Neuro-Chirurgie
|
July 23, 2023
Juvenile xanthogranuloma as a differential diagnosis for sellar and suprasellar lesions in child: Case report and review of literature
I S Rios, D R Silva, P E Goncalves, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1992
[Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies]
P Carde, C Chastang, E Goncalves, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 1993
Optimizing transmembrane domain helicity accelerates insulin receptor internalization and lateral mobility
E Goncalves, K Yamada, H S Thatte, et al.
European Journal of Sport Science
|
August 23, 2014
Motivation towards dual career of European student-athletes
Corrado Lupo, Flavia Guidotti, Carlos E Goncalves, et al.
Neuro-Chirurgie
|
July 23, 2023
Juvenile xanthogranuloma as a differential diagnosis for sellar and suprasellar lesions in child: Case report and review of literature
I S Rios, D R Silva, P E Goncalves, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie
|
January 1, 1992
[Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies]
P Carde, C Chastang, E Goncalves, et al.
Page
of 2